Get the Stockscreener App
6.13
1.29%
-0.08
After Hours:
6.13
Kezar Life Sciences Inc stock is traded at $6.13, with a volume of 121.80K.
It is down -1.29% in the last 24 hours and up +56.38% over the past month.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
See More
Previous Close:
$6.21
Open:
$6.21
24h Volume:
121.80K
Relative Volume:
0.73
Market Cap:
$45.48M
Revenue:
$7.00M
Net Income/Loss:
$-70.79M
P/E Ratio:
-0.6326
EPS:
-9.69
Net Cash Flow:
$-64.34M
1W Performance:
-0.97%
1M Performance:
+56.38%
6M Performance:
+36.22%
1Y Performance:
-14.98%
1-Day Range:
$6.05
$6.21
1-Week Range:
$6.05
$6.30
52-Week Range:
$3.5334
$7.65
Kezar Life Sciences Inc Stock (KZR) Company Profile
Name
Kezar Life Sciences Inc
Sector
Industry
Phone
650-822-5600
Address
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare KZR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KZR
Kezar Life Sciences Inc
|
6.13 | 45.48M | 7.00M | -70.79M | -64.34M | -9.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kezar Life Sciences Inc Stock (KZR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-17-25 | Downgrade | Jefferies | Buy → Hold |
| Oct-17-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-11-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-16-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-08-21 | Initiated | Wells Fargo | Overweight |
| Jul-16-18 | Initiated | Jefferies | Buy |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
| Jul-16-18 | Initiated | William Blair | Outperform |
View All
Kezar Life Sciences Inc Stock (KZR) Latest News
Can Kezar Life Sciences Inc. stock maintain growth trajectoryMarket Performance Report & Free Expert Approved Momentum Trade Ideas - newser.com
Is Kezar Life Sciences Inc. (2KZ0) stock attractive for dividend growthJuly 2025 Earnings & Stepwise Swing Trade Plans - newser.com
What Wall Street predicts for Kezar Life Sciences Inc. stock priceJuly 2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Is Kezar Life Sciences Inc. stock a buy on dipsJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - newser.com
Applying Elliott Wave Theory to Kezar Life Sciences Inc.Earnings Growth Report & Safe Entry Zone Identification - newser.com
Is Kezar Life Sciences Inc. stock a safe haven asset2025 Fundamental Recap & Reliable Intraday Trade Alerts - newser.com
How institutional buying supports Kezar Life Sciences Inc. stockInflation Watch & Reliable Intraday Trade Plans - newser.com
How Kezar Life Sciences Inc. stock compares to industry benchmarksBreakout Watch & Risk Adjusted Swing Trade Ideas - newser.com
Top chart patterns to watch in Kezar Life Sciences Inc.2025 Dividend Review & Weekly Market Pulse Updates - newser.com
Will Kezar Life Sciences Inc. stock continue upward momentumQuarterly Earnings Summary & Safe Entry Zone Identification - newser.com
Developing predictive dashboards with Kezar Life Sciences Inc. dataQuarterly Trade Report & Growth Focused Entry Reports - newser.com
Is Kezar Life Sciences Inc. stock attractive for growth ETFsMarket Movement Recap & AI Based Buy and Sell Signals - newser.com
Kezar Life Sciences Inc. stock prediction for this weekFed Meeting & Low Drawdown Trading Strategies - newser.com
Advanced analytics toolkit walkthrough for Kezar Life Sciences Inc.Earnings Recap Report & Verified Chart Pattern Signals - newser.com
Is a relief rally coming for Kezar Life Sciences Inc. holdersJuly 2025 Patterns & Reliable Volume Spike Alerts - newser.com
Real time pattern detection on Kezar Life Sciences Inc. stock2025 Sector Review & Safe Entry Point Alerts - newser.com
Backtesting results for Kezar Life Sciences Inc. trading strategiesWeekly Profit Report & Daily Volume Surge Trade Alerts - newser.com
Published on: 2025-11-01 12:41:38 - newser.com
Published on: 2025-11-01 12:24:27 - newser.com
Visual trend scoring systems applied to Kezar Life Sciences Inc.2025 Price Action Summary & Reliable Entry Point Trade Alerts - newser.com
Can Kezar Life Sciences Inc. (2KZ0) stock sustain double digit ROEWeekly Profit Report & Verified Entry Point Detection - newser.com
Kezar Life Sciences, Inc.Common Stock (NQ: KZR - FinancialContent
Kezar Life Sciences (KZR) Price Target Decreased by 52.00% to 6.12 - MSN
Can Kezar Life Sciences Inc. stock continue upward trendWeekly Investment Report & Verified Entry Point Signals - newser.com
Why Kezar Life Sciences Inc. (2KZ0) stock attracts wealthy investorsChart Signals & Real-Time Chart Pattern Alerts - newser.com
How Kezar Life Sciences Inc. stock reacts to inflationary pressuresMarket Trend Review & Technical Buy Zone Confirmations - newser.com
Published on: 2025-10-31 03:56:34 - newser.com
Why hedge funds are buying Kezar Life Sciences Inc. stockJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Building trade automation scripts for Kezar Life Sciences Inc.Trade Analysis Summary & Real-Time Market Sentiment Alerts - newser.com
Kezar Life Sciences Faces Existential Crisis After Clinical Trial Setback - AD HOC NEWS
Kezar Life Sciences Inc Stock (KZR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):